Apellis Pharmaceuticals
APLS
Reported
Tuesday, February 21
Q4 2022 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | -1.57 | -1.50 | 0.07 | 4.46% |
| Revenue | 24.2M | 22.7M | -1.53M | -6.31% |
WhatIF - Earnings
EPS Beat Expectations by $0.07
Apellis Pharmaceuticals (APLS:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything